Medtronic plc
Pharmaceutical & Health Products · Lobbying Client
Medtronic plc's Federal Lobbying Record
Medtronic plc's $10.0M in disclosed federal lobbying puts it in the mid-tier of registered filers. Spending in the seven-figure range is common for established trade groups, mid-size corporations, and advocacy organizations that maintain a steady but not aggressive presence on Capitol Hill.
Across the 5-year window from 2020 to 2024, Medtronic plc's annual disclosed lobbying spend has climbed meaningfully — from $1.8M in 2020 to $2.4M in 2024, a change of +39%. Step-changes of this size often coincide with major bills moving through Congress, regulatory rulemakings affecting the organization's industry, or a leadership change in the relevant committee.
Medtronic plc's disclosed lobbying covers 5 general issue areas — a moderate footprint. Filers in this range tend to engage on a coherent cluster of related topics rather than spreading effort across the federal agenda.
1 of 7 lobbyists reported by Medtronic plc (14%) disclose prior federal government service — a small minority of the named bench.
Among the named bench, lobbyists with disclosed prior federal service include Douglas B. Steenland (Former Counsel, Senate Judiciary Committee). The covered-position field on LDA cover sheets captures executive-branch and senior congressional roles held within the prior two years.
Within the Pharmaceutical & Health Products sector, Medtronic plc ranks #18 of 34 tracked organizations by disclosed lobbying spend. The sector leader is Pharmaceutical Research & Manufacturers of America at $135.8M; the sector average is $16.7M. Medtronic plc's $10.0M sits 40% below the sector average.
Medtronic plc's LobbySpend Influence Score of 50/100 (grade C) is the most common grade in the index — it covers organizations with established but moderate federal advocacy programs. The score combines disclosed total spend (40%), issue breadth (30%), and revolving-door connections (30%). A C-grade is typical of mid-size corporations and trade associations with steady quarterly filings on a focused issue set.
Every figure above is sourced from Senate lobbying disclosure filings submitted under the Lobbying Disclosure Act of 1995. Per-issue dollar splits and covered-position flags are filer-reported and may be amended after initial submission.
Track Medtronic plc's lobbying filings
Subscribe for LobbySpend updates by email. No spam, unsubscribe anytime.
Annual Lobbying Spend
Policy Issues
Government Entities Contacted
Recent Filings
| Period | Registrant | Issues | Lobbyists | Amount |
|---|---|---|---|---|
| 2024 Oct-Dec | Covington & Burling | MEDTAXTRD+2 | 2 | $596K |
| 2024 Jul-Sep | Williams & Jensen | HCRTAX | 4 | $525K |
| 2024 Apr-Jun | Cassidy & Associates | TAXTRDGOV | 1 | $577K |
| 2024 Jan-Mar | Holland & Knight | GOVMED | 2 | $713K |
| 2023 Oct-Dec | DLA Piper | HCRTRDMED+2 | 3 | $494K |
| 2023 Jul-Sep | Podesta Group | TAXTRDGOV+1 | 1 | $591K |
| 2023 Apr-Jun | Invariant LLC | TRDTAXHCR+2 | 4 | $573K |
| 2023 Jan-Mar | Prime Policy Group | TRDTAXHCR+1 | 4 | $461K |
Medtronic plc Lobbying FAQ
Medtronic plc has spent $10.0M on federal lobbying across 5 policy areas. This includes spending on registered lobbyists and direct government contacts.
Medtronic plc lobbies on 5 policy issues, including Health Issues, Medical/Disease Research, Taxation, Trade. These disclosures are filed quarterly with the Senate Office of Public Records.
Medtronic plc has an Influence Score of 50/100 (Grade C). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).
Medtronic plc employs 7 registered lobbyists, of whom 1 have revolving door connections, meaning they previously held government positions before becoming lobbyists.
Medtronic plc has contacted 6 government entities as part of their lobbying activities, including Dept of Education, Federal Communications Commission, U.S. Senate.
Explore Other Lobbying Organizations
$387.8M lobbying spend · Trade Association · Influence Score B
$348.2M lobbying spend · Real Estate · Influence Score B
$135.8M lobbying spend · Pharmaceutical & Health Products · Influence Score B
$128.0M lobbying spend · Healthcare · Influence Score B
Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.